Fully gas saturated coals suggest probability of high class resource for EXR

|

Published 08-JUL-2020 10:01 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Elixir Energy Limited (ASX:EXR) has provide a positive update on its laboratory adsorption testing results , announcing fully gas saturated coals identified in Nomgon-1.

The final key laboratory test results from the Nomgon-1 well which was announced as being a coal seam gas discovery on 26 February 2020 have now been completed.

Elixir managing director Neil Young was buoyed by the results, and he explained the subsequent implications in saying, “Identifying fully gas saturated coals in Nomgon-1 is an excellent result, given the very positive consequences this should have for coal seam gas pilot production testing and ultimately a field development.

‘’Nomgon-1’s very thick coals that have now been identified as being fully gas saturated, suggesting a potentially very high class resource has been found.”

As a backdrop, travel and other restrictions due to COVID-19 delayed the volume and timing of transmission of coal samples to an international standard SGS laboratory in China for some months, but moving forward this is expected to be smoother.

Due to these limitations, only one sample was analysed in the main “100 series” coal seam, but a broader range of samples will be tested in future.

The resultant adsorption isotherm data derived from this main seam test, combined with the wellsite desorption analysis, proximate analysis, gas chromatography and Injectivity Fall Off Testing (IFOT), are interpreted to indicate this main coal to be near fully gas saturated.

Although there is a complex interaction between the multiple different factors that characterise a coal seam gas play, there are potentially very positive consequences of full gas saturation for a coal seam gas play.

Nomgon-2 ready to spud ahead of Nomgon-1 pilot test

One of the key factors is that the pilot production design could be substantially simpler and cheaper.

On this note, management is aiming to conduct a pilot production testing 2021 provided a successful appraisal campaign can be executed in 2020.

Production testing should be characterised by early gas production, not a lengthy water producing phase to induce pressure draw-down and gas breakthrough.

Water management issues in the development phase could become simpler and cheaper, hence significantly improving gas production economics.

While this news in itself should be positively received, it is also worth noting that the Nomgon-2 well is due to spud very shortly.

This well is intended to produce the same suite of test results as its predecessor Nomgon-1.

These results will become progressively available after the well reaches its target depth and samples are either analysed on-site or sent to laboratories in Mongolia and China.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X